Newsletter
S2 008: Christoph Ruedig. Investing in healthtech at Albion. 🏥📲💸

The Healthtech VC

S2 008: Christoph Ruedig. Investing in healthtech at Albion. 🏥📲💸

July 9, 2022

S2 008: Christoph Ruedig. Investing in healthtech at Albion. 🏥📲💸

A former radiologist turned investor, Christoph Ruedig discusses his journey to healthtech from medical school and radiology to management consulting, an MBA from Insead and now being Partner at Albion. One of the original doctor-turned-investors, Christoph has been investing for over a decade since the days that healthtech was called healthcare I.T. !

We discuss Albion, a venture capital fund manager with circa £850M in assets under management and their investing thesis. Christoph highlights a couple of Albion’s healthtech portfolio companies. We also touch on what makes a good board, the benefits of doing an MBA and what healthtech companies should think about in a market downturn.

As another radiologist-turned-investor, I have found Christoph to be an inspiration and support to me. I hope you enjoy this conversation.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Preventing Blindness with Early Mobile Eye Disease Detection Spect CEO discusses eye disease screenings for early diagnosis and treatment.